STOCK MARKET BSE NSE

Price cap blocks supply of stents, say Bengaluru hospitals

Hospitals in the city say stocks of third and fourth generation stents are fast drying up and they cannot procure fourth generation stents at current prices.

Published: 02nd March 2017 05:03 AM  |   Last Updated: 02nd March 2017 07:32 AM   |  A+A-

(File Photo | AP)

Express News Service

BENGALURU: Fifteen days after the National Pharmaceutical Pricing Authority (NPPA) ordered a cap on the prices of coronary stents, hospitals in the city say stocks of third and fourth generation stents are fast drying up and they cannot procure fourth generation stents at current prices.

Dr C N Manjunath, director, Jayadeva Institute of Cardiovascular Sciences, the country’s premier government heart hospital, said that fourth generation drug eluting stents were being used in the hospital and they are no longer available. 

“Importers are saying they cannot procure fourth generation stents for Rs 30,000 a piece. The NPPA capped its price at Rs 29,600. We are not able to give appropriate treatment for different heart conditions. The issue with older generation stents is that the risk of restenosis is high,” he said. 

Illustration: Suvajit Dey

Restenosis is the recurrence of stenosis, a narrowing of a blood vessel leading to restricted blood flow. Restenosis usually pertains to an artery or other large blood vessel that has become narrow, received treatment to clear the blockage and subsequently become narrowed again. 

Dr Subhash Chandra, HoD, Cardiology at Manipal Hospital said, “We are using third generation stents that are available on our shelf.” 

Dr A Gopi, HoD, Cardiology, Fortis Hospital, Cunningham Road, said, “We have stock of third and fourth generation stents. Patients have made passing comments on this issue. Once the stock is exhausted, we will request the companies to provide more. They are bound by the law to provide more.”

Dr Girish, cardiologist at Apollo Hospital, said, “We have third generation stents, but not fourth generation bioresorbable stents. Companies have taken back biodegradable stents. It costs around Rs 1,80,000. Since the cap order, we haven’t had the opportunity to use them. If a patient specifically requests for it, we will request the company to provide it and will do the surgery if the company supplies it.”

When contacted, NPPA chairman Bhupendra Singh said, “Before coronary stents were added to the list of essential medicines, an expert committee of 18 cardiologists was constituted by the Union health ministry. They felt the treatment outcomes are same, hence we went ahead with capping the price.”

Stay up to date on all the latest Bengaluru news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp